Purpose To evaluate the effect of epoetin alfa (EPO) on left ventricular hypertrophy in pre-dialysis patients.
目的评价慢性肾衰竭透析前患者使用阿法依泊汀(epoetinalfa,EPO,促红细胞生成素)对左心室肥大(leftventricularhypertrophy,LVH)的影响。
6ug/Kg groups) who were stableon hemodialysis over 3 months were included to evaluate thepharmacokinetics and security of darbepoetin alfa.
为了评估达依泊汀α在中国维持性血透患者中单次静脉给药的安全性和药代动力学特性，本课题对透析3个月以上稳定期慢性肾衰竭患者43例(分为0。